Indication

Pneumococcal pneumonia

Pneumococcal pneumonia is an acute lower respiratory tract infection caused by the bacterium *Streptococcus pneumoniae*, representing one of the leading causes of bacterial community-acquired pneumonia. Read more about Pneumococcal pneumonia

420 drugs 160 manufacturers

Advertisement

Drugs that treat it

Common Pneumococcal pneumonia therapies.

Showing 316–324 of 420 drugs

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
BRYANT RANCH PR

CLINDAMYCIN HCL

CLINDAMYCIN SYSTEMIC·SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19
BRYANT RANCH PR

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
RISING PHARM
Filter & compare in the drug finder →Opens the drug finder with Pneumococcal pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pneumococcal pneumonia.

Pneumococcal pneumonia is an acute lower respiratory tract infection caused by the bacterium *Streptococcus pneumoniae*, representing one of the leading causes of bacterial community-acquired pneumonia.

It affects the pulmonary parenchymal tissue—frequently producing lobar consolidation—and disproportionately impacts adults aged 65 and older, children younger than 5, and individuals with chronic cardiopulmonary diseases or immunocompromising conditions.

The clinical state is characterized by alveolar inflammation, purulent exudation, and impaired gas exchange, manifesting with an abrupt onset of fever, rigors, dyspnea, pleuritic chest pain, and a productive cough that often yields classic rust-colored sputum.

Personalize your experience

Follow Pneumococcal pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it